Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial

LESSONS LEARNED: The efficacy of single‐agent chemotherapy was not significantly different from that of double‐agent chemotherapy in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma. Single‐agent concurrent chemoradiotherapy had lower gastrointestinal and hematologic to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhenhuan, Wen, Yixue, Liao, Dongbiao, Miao, Jidong, Gui, Yan, Cai, Hongwei, Chen, Yang, Wei, Min, Jia, Qiang, Tian, Honggang, Sun, Mingqiang, Zhang, Yu, Feng, Gang, Du, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108049/
https://www.ncbi.nlm.nih.gov/pubmed/32864805
http://dx.doi.org/10.1634/theoncologist.2020-0808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108049/
https://www.ncbi.nlm.nih.gov/pubmed/32864805
http://dx.doi.org/10.1634/theoncologist.2020-0808

Ejemplares similares